Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Alzheon is a clinical-stage biotechnology company that develops treatment for neurodegenerative disorders.
Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.
Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.
Calyxo is a medical device company that improves kidney stone treatment through specialized urology technologies.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.
Kandu Health is a tech-enabled healthcare company that provides stroke recovery training, stroke detection research, and education services.
Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.
Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.
Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.
SetPoint Medical provides a device-based therapy for rheumatoid arthritis.
VitalConnect offers wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations.
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.
Context Therapeutics is a clinical-stage biopharmaceutical company.
Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.
Quantum Surgical mission is to democratize minimally invasive liver cancer treatment
Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.
Elligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies.
Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.
MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.
Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.
MindMed provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.
Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.
Ally Bridge Group has invested in 47 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Ally Bridge Group's top investment sectors include Health Care, Biotechnology, Medical, Medical Device, Therapeutics. The firm invests across 19 different industry categories.
Among tracked funding rounds, Definium Therapeutics received $805.0M in a Post-IPO Equity round. Ally Bridge Group's total known invested capital is $5.2B.
Ally Bridge Group's average investment size is $111.5M across its portfolio of 47 companies.
Recent Ally Bridge Group portfolio additions include Alzheon, Definium Therapeutics, Whitehawk Therapeutics, Calyxo, Imperative Care. These companies were founded in 2020 or later.